April 14, 2026

Genomic testing finds a higher prevalence of high-risk breast cancer in Black women

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

By Bill Snyder